10th Edition of
World Congress on Infectious Diseases & One Health
October 05-07, 2026 | Tokyo, Japan
The pathogenesis of Haemorrhagic Fever involves a complex interplay between the viral infection and the host's immune response. These viruses often target endothelial cells, leading to increased vascular permeability and, subsequently, bleeding manifestations. Clinical features vary depending on the specific virus but commonly include fever, fatigue, muscle pain, and, in severe cases, bleeding from various sites such as the gums, nose, and gastrointestinal tract. Organ failure may ensue, contributing to the high mortality associated with certain Haemorrhagic Fever viruses. Disseminated intravascular coagulation (DIC) is a common complication, where the normal blood clotting process becomes dysregulated, further contributing to bleeding tendencies. Understanding the pathophysiology and clinical manifestations is crucial for timely diagnosis and appropriate medical intervention.
Title : Molecular crosstalk between the host and pathogen in Streptococcus pyogenes virulence
Francis J Castellino, University of Notre Dame, United States
Title : Phenotypic characterisation of non tuberculous mycobacterium species isolated from clinical specimens
Anant Marathe, Parul Institute of Medical Sciences and Research, Parul University, India
Title : Praziquantel for the treatment of preschool-aged children with schistosomiasis: Results of an RCT
Susannah Colt, Warren Alpert Medical School of Brown University, United States
Title : Carbapenemase-producing multidrug resistance of gram negative bacilli causing bacteremia at the general hospital of Mexico during the Covid-19 pandemic
Silvia Giono, Instituto Politecnico Nacional, Mexico
Title : The largest histamine poisoning outbreak in Brazil: An experience report from a one health perspective in Fernando de Noronha
Camila Ferro, Fundacao Oswaldo Cruz (Fiocruz), Brazil
Title : Combating antimicrobial resistance in sub-Saharan Africa: Advancing one health strategies for sustainable infectious disease control
Ugorji Miracle Enyinnaya, Greatlink Pharmaceutical, Nigeria